American International Group, Inc. Galectin Therapeutics Inc Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.07 - $5.1 $44,871 - $110,552	-21,677 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.96 - $2.57 $113 - $149	58 Added 0.27%	21,677 $47,000
Q4 2020 Feb 12, 2021	SELL	$2.24 - $2.87 $1,393 - $1,785	-622 Reduced 2.8%	21,619 $48,000
Q3 2020 Nov 04, 2020	SELL	$2.53 - $3.64 $1,277 - $1,838	-505 Reduced 2.22%	22,241 $59,000
Q2 2020 Aug 12, 2020	SELL	$1.66 - $3.15 $1,603 - $3,042	-966 Reduced 4.07%	22,746 $70,000
Q1 2020 May 04, 2020	SELL	$1.51 - $3.0 $2,068 - $4,110	-1,370 Reduced 5.46%	23,712 $46,000
Q4 2019 Feb 05, 2020	SELL	$2.79 - $4.32 $591 - $915	-212 Reduced 0.84%	25,082 $72,000
Q3 2019 Nov 08, 2019	BUY	$3.0 - $4.05 $14,364 - $19,391	4,788 Added 23.35%	25,294 $93,000
Q2 2019 Aug 13, 2019	BUY	$3.61 - $5.0 $74,026 - $102,530	20,506 New	20,506 $85,000

9.69M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.